ImmunityBio Inc IBRX
NASDAQ · United States · Health Technology
$9.30-0.14 (-1.54%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -0.22 | -0.08 | -175.0% | $51.24M | +3.1% | +1.4%$7.15→$7.25 |
| Q1 2026 | 2026-05-07 | -0.08 | -0.07 | -14.3% | — | — | +1.6%$8.38→$8.51 |
| Q4 2025 | 2026-02-23 | -0.06 | -0.10 | +40.0% | — | — | +32.8%$8.70→$11.55 |
| Q3 2025 | 2025-11-04 | -0.07 | -0.10 | +30.0% | — | — | -4.9%$2.26→$2.15 |
| Q2 2025 | 2025-08-05 | -0.10 | -0.10 | 0.0% | — | — | — |
| Q1 2025 | 2025-05-12 | -0.15 | -0.14 | -7.1% | — | — | — |
| Q4 2024 | 2025-03-03 | -0.08 | -0.13 | +38.5% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.12 | -0.18 | +33.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.